277 related articles for article (PubMed ID: 34552622)
1. Establishment and Validation of a Genetic Label Associated With M2 Macrophage Infiltration to Predict Survival in Patients With Colon Cancer and to Assist in Immunotherapy.
Xu B; Peng Z; Yan G; Wang N; Chen M; Yao X; Sun M; An Y
Front Genet; 2021; 12():726387. PubMed ID: 34552622
[TBL] [Abstract][Full Text] [Related]
2. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
3. Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy.
Wu Z; Lei K; Li H; He J; Shi E
J Transl Med; 2022 Oct; 20(1):489. PubMed ID: 36303162
[TBL] [Abstract][Full Text] [Related]
4. Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma.
Xu C; Song L; Yang Y; Liu Y; Pei D; Liu J; Guo J; Liu N; Li X; Liu Y; Li X; Yao L; Kang Z
Front Oncol; 2022; 12():919899. PubMed ID: 35936688
[TBL] [Abstract][Full Text] [Related]
5. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer.
Guo JN; Chen D; Deng SH; Huang JR; Song JX; Li XY; Cui BB; Liu YL
Cancer Immunol Immunother; 2022 Jun; 71(6):1313-1330. PubMed ID: 34657172
[TBL] [Abstract][Full Text] [Related]
7. Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma.
Song H; Wang X; Zhang C; He J
Front Oncol; 2023; 13():1170775. PubMed ID: 37409259
[TBL] [Abstract][Full Text] [Related]
8. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
[TBL] [Abstract][Full Text] [Related]
9. Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy.
Yang D; Zhao F; Su Y; Zhou Y; Shen J; Zhao K; Ding Y
Front Mol Biosci; 2023; 10():1184708. PubMed ID: 37469705
[No Abstract] [Full Text] [Related]
10. A comprehensive pan-cancer analysis identifies a novel glycolysis score and its hub genes as prognostic and immunological biomarkers.
Zheng D; Long S; Xi M
Transl Cancer Res; 2023 Oct; 12(10):2852-2874. PubMed ID: 37969385
[TBL] [Abstract][Full Text] [Related]
11. M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer.
Wang Y; Yan K; Wang J; Lin J; Bi J
Front Oncol; 2021; 11():609334. PubMed ID: 33828973
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and immunotherapy response prediction based on M2 macrophage-related genes in colon cancer.
Xu X; Zhang X; Kou R; Liu Y; Chen S; Li Z; Jian Z; Wang Z
J Cancer Res Clin Oncol; 2024 Jan; 150(2):31. PubMed ID: 38270646
[TBL] [Abstract][Full Text] [Related]
13. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma.
Xu Q; Chen S; Hu Y; Huang W
Cancer Cell Int; 2021 Oct; 21(1):582. PubMed ID: 34717651
[TBL] [Abstract][Full Text] [Related]
14. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
[TBL] [Abstract][Full Text] [Related]
15. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
Yan K; Wang Y; Lu Y; Yan Z
J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
[TBL] [Abstract][Full Text] [Related]
16. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
18. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
Front Genet; 2021; 12():623424. PubMed ID: 33664769
[TBL] [Abstract][Full Text] [Related]
19. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
Wang X; Duanmu J; Fu X; Li T; Jiang Q
J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
[TBL] [Abstract][Full Text] [Related]
20. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
Kang K; Xie F; Mao J; Bai Y; Wang X
Front Oncol; 2020; 10():573141. PubMed ID: 33072607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
